Hypoglycemia

269 registered clinical trials studyying Hypoglycemia — 23 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	FEAR of HYPOGLYCEMIA in PATIENTS WITH DIABETES NCT07329985	Bilecik Seyh Edebali Universitesi	—
Recruiting	Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events NCT06893341	Indiana University	N/A
Recruiting	"Sexual Activity and Hypoglycemia Risk in Adults With Type 1 or Type 2 Diabetes Using Insulin Therapy and Cont NCT07286500	Medical University of Warsaw	—
Recruiting	External Carotid Blood Flow in Individuals With Post-Bariatric Hypoglycemia NCT07082478	Joslin Diabetes Center	—
Recruiting	A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 NCT06575426	Otsuka Pharmaceutical Factory, Inc.	Phase 1 / Phase 2
Enrolling By Invitation	Frequency of Hypoglycemia in Children With Beta-blocker Treated Long QT-syndrome NCT07233421	Helsinki University Central Hospital	N/A
Active Not Recruiting	Glucagon Dose-Response in Patients With Post-Bariatric Hypoglycemia NCT06986603	Joslin Diabetes Center	Phase 4
Withdrawn	CGM/Clarity Use, Glycemic Control and Clinical Outcomes NCT03827434	University of Maryland, Baltimore	N/A
Recruiting	Continuous Glucose Monitoring in HIE NCT06563687	University of Campania Luigi Vanvitelli	N/A
Withdrawn	Diabetes Islet Preservation Immune Treatment NCT02586831	Camillo Ricordi and Jay Skyler	Phase 1 / Phase 2
Recruiting	Effect of C-peptide on Hypoglycemic Counterregulation NCT06470295	University of Cincinnati	EARLY_Phase 1
Completed	Study of a Primary Care Hypoglycemia Prevention Program NCT06353217	Johns Hopkins University	N/A
Recruiting	Safer Aging With Diabetes Monitoring NCT06296485	Kaiser Permanente	N/A
Completed	Postprandial Hypotension and Insulin Levels NCT06657287	Ankara Yildirim Beyazıt University	—
Recruiting	Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes NCT06297980	University of Colorado, Denver	N/A
Completed	Hypoglycemia Biomarkers to Predict Timing of a Hypoglycemic Event NCT06652867	Royal College of Surgeons in Ireland - Medical University of Bahrain	—
Suspended	Concordance of Hypoglycemia Measurement With Simultaneous Use of Two Devices for Continuous Glucose Measuremen NCT06246578	Central Jutland Regional Hospital	N/A
Completed	The Construction and Validation of a Risk Prediction Model for Perioperative Hypoglycemia in Digestive Endosco NCT07132476	Ningbo No. 1 Hospital	—
Completed	Role of Adrenaline in in the Inflammatory Response in Diabetes NCT05990933	Cees Tack	N/A
Recruiting	Continuous Subcutaneous Glucose Monitoring in Critical Patients NCT06234787	Universidad Europea de Madrid	—
Recruiting	A Study of Glycemic Control in Left Ventricular Assist NCT05933161	Mayo Clinic	—
Completed	Pilot Feasibility Study for HypoPals, a Mobile Health Program for Improving Hypoglycemia Management. NCT05916131	University of Michigan	N/A
Unknown	Nurse Coaching the Effect of on Glycemic Control, Fear of Hypoglycemia and Risk Perception in Adults With Type NCT05870280	Tuğba Bilgehan	N/A
Completed	Effects of a Health Intervention on Hypoglycemic Coping : a Pilot Study NCT06384118	Yating Liu	N/A
Withdrawn	Slow Digestible Carbohydrates and Exercise in Adolescents With Type 1 Diabetes NCT05540132	State University of New York at Buffalo	N/A
Recruiting	CGM-Assisted Management of PN NCT05902104	Boston Children's Hospital	—
Recruiting	Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes NCT05643144	Indiana University	N/A
Completed	A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With NCT05378672	Zealand Pharma	Phase 3
Completed	Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes NCT05616273	University of Exeter	—
Completed	Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients NCT05442853	Malcom Randall VA Medical Center	N/A
Withdrawn	Micro Glucagon During Exercise in Type 1 Diabetes NCT04192019	Insel Gruppe AG, University Hospital Bern	EARLY_Phase 1
Unknown	Continuous Glucose Monitoring for Emergency Laparotomy NCT05641792	Medical University of Gdansk	N/A
Completed	Continous Glucose Monitoring in Neonates at Risk of Hypoglycaemia- a Feasibility Study NCT07375615	Sykehuset Innlandet HF	—
Completed	Investigating the Relationship Between Nocturnal Glucose Levels and Motion During Sleep NCT05609175	University of Bern	—
Withdrawn	Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass ( NCT04824872	Zealand Pharma	Phase 2
Recruiting	Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal NCT05640947	University Hospital, Ghent	N/A
Completed	GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU) NCT03890432	HEIDEGGER CP	N/A
Unknown	Remote Glucose Monitoring in Hospital Settings NCT04797208	Manchester University NHS Foundation Trust	N/A
Completed	The Effect of Physical Activity in Individuals With Post-bariatric Hypoglycemia NCT05560789	Joslin Diabetes Center	N/A
Unknown	Galactose - the Ideal Carbohydrate Supplement for Exercise in Type 1 Diabetes NCT05557227	University of Aarhus	N/A
Completed	Prehospital Provider Training With Augmented Reality (AR) NCT05686590	Thomas Caruso	N/A
Completed	Neuronostatin - a Glucagonotropic Agent in Humans? NCT06143267	University Hospital, Gentofte, Copenhagen	N/A
Completed	The HypoVoice Study NCT05569876	Insel Gruppe AG, University Hospital Bern	N/A
Completed	Glucagon and Advanced HCL System to Prevent Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes NCT05379686	Steno Diabetes Center Copenhagen	N/A
Completed	The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects NCT05597605	Indigo Diabetes NV	N/A
Unknown	FreeStyle Libre 2 Discharge Trial NCT05822232	Palo Alto Medical Foundation	N/A
Completed	The Effect of Glucose-dependent Insulinotropic Polypeptide on the Alpha Cell Response to Hypoglycaemia in Pati NCT06137586	University Hospital, Gentofte, Copenhagen	N/A
Recruiting	Diabetes Clinical Decision Support NCT05447806	Milton S. Hershey Medical Center	N/A
Unknown	Acute Changes in Plasma Glucose and Cardiovascular Disease in Diabetes NCT05500352	Steno Diabetes Center Copenhagen	N/A
Completed	Continuous Glucose Monitoring (CGM) in Long Term Care (LTC) Facilities NCT05711108	Joslin Diabetes Center	—
Completed	Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes NCT05076292	Steno Diabetes Center Copenhagen	N/A
Unknown	Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observati NCT05087225	Ministry of Health, Saudi Arabia	—
Completed	The Effectiveness of Multimedia Education on Hypoglycemic Management. NCT06516705	Kaohsiung Medical University Chung-Ho Memorial Hospital	N/A
Unknown	Electronic Platform for Diabetic Patients Activation NCT04595383	Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana	N/A
Completed	The SMART B Exercise Study :''The SMART Study'' NCT05133765	Steno Diabetes Center Copenhagen	N/A
Completed	The Effect of 'Medical Nutrition Therapy' on Post-bariatric Hypoglycemia 2-4 Years After Gastric Bypass Surger NCT05011682	Helse Nord-Trøndelag HF	N/A
Completed	Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes NCT04614168	University of Edinburgh	N/A
Completed	The Effect of Motivational Interviewing in Children With Type 1 Diabetes NCT06424574	Yuzuncu Yil University	N/A
Completed	Analysis of Related Risk Factors of Hypoglycemia Consciousness Disorder NCT04971070	Chongqing Renji Hospital, University of Chinese Academy of Sciences	—
Terminated	Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus NCT05007977	Zucara Therapeutics Inc.	Phase 1
Suspended	A Study to Improve Diabetes Management Among Adults Experiencing Severe Hypoglycemia NCT04874532	Mayo Clinic	N/A
Active Not Recruiting	Cardiac Arrhythmia in Patients with End-Stage Renal Disease NCT04841304	Rigshospitalet, Denmark	—
Completed	Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diab NCT04764968	Steno Diabetes Center Copenhagen	Phase 2
Terminated	Continuous Glucose Monitoring Initiation at Hospital Discharge NCT04854135	Washington University School of Medicine	N/A
Completed	Comparison of Ease of Use and Acceptability of Intranasal and Injectable Glucagon Among Providers Administerin NCT05395000	CHU de Quebec-Universite Laval	N/A
Completed	EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY NCT04692623	Shaheed Benazir Bhutto University Sheringal Dir Upper	Phase 1
Completed	CGM Use in Poorly Controlled Youth With Type 1 Diabetes NCT04721145	Johns Hopkins University	N/A
Unknown	Diabetes Type One in Pregnancy and Continuos Glucose Monitoring NCT04997460	Clinical Hospital Centre Zagreb	—
Completed	Reducing Treatment Risk in Older Adults With Diabetes NCT04585191	Kaiser Permanente	N/A
Completed	Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS NCT04304963	King's College London	—
Recruiting	DiGESTnewborn Study NCT04192422	Cambridge University Hospitals NHS Foundation Trust	—
Completed	Impact of Glycemic Control After Reperfusion on Acute Kidney Injury in Living Donor Liver Transplantation NCT06320730	Asan Medical Center	—
Completed	Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Complications in Diabetic Patients NCT04430660	Pennington Biomedical Research Center	N/A
Completed	Glycemic Control Before, During and After the 2016 Paris Marathon NCT04926298	University Hospital, Brest	—
Active Not Recruiting	Mechanisms of Hypoglycemia in Patients Without Diabetes NCT04428723	Joslin Diabetes Center	—
Completed	Cognition in Patients With Hypoglycemia, Without Diabetes NCT04430582	Joslin Diabetes Center	—
Completed	Assessing Insulin Turnover Using an In-vivo Deuterated Water Experiment. NCT04332289	Lia Bally	—
Completed	Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes NCT04449692	Steno Diabetes Center Copenhagen	Phase 2
Completed	Wireless Assessment of Respiratory and Circulatory Distress - Continuous Glucose Monitoring NCT04473001	University Hospital Bispebjerg and Frederiksberg	—
Recruiting	French National Cohort of People With Type 1 Diabetes NCT04657783	Fondation Francophone pour la Recherche sur le Diabete	—
Terminated	Effects of a Hypoglycemia Protocol With Glucose Gel on Neonatal Intensive Care Unit (NICU) Admission NCT04085978	Pediatrix	—
Unknown	Mechanisms of Post-Bariatric Hypoglycemia NCT04428866	Joslin Diabetes Center	—
Completed	A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus NCT04050553	Eli Lilly and Company	Phase 1
Recruiting	Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation NCT04207619	Pennington Biomedical Research Center	N/A
Completed	Investigating Novel Predictions of Hypoglycemia Occurrence in Real-world Models NCT04219514	Stewart Harris	—
Unknown	Continuous Glucose Monitoring (CGM) After Surgical Variations of the Roux-en-y Gastric Bypass NCT04172116	Medical University of Vienna	—
Completed	Hypoglycemia and Glucagon Response in CF NCT05700604	Marmara University	—
Recruiting	Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes NCT05973799	University of Cincinnati	N/A
Completed	The Functional Neuroanatomy of the Human Physiological Stress Response NCT03867344	Brigham and Women's Hospital	N/A
Terminated	Insulin Tolerance Test Study in Patients With Type 1 Diabetes NCT04026750	High Point Clinical Trials Center	Phase 1
Completed	24/7 Closed-loop in Older Subjects With Type 1 Diabetes NCT04025762	University of Cambridge	N/A
Withdrawn	Introducing CGM at Type 1 Diabetes Diagnosis NCT03736083	University of Florida	N/A
Completed	Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults NCT03841526	Xeris Pharmaceuticals	Phase 2
Completed	Consequences of Hypoglycaemia on Cardiovascular and Inflammatory Responses NCT03976271	Radboud University Medical Center	N/A
Completed	Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes NCT04053712	Steno Diabetes Center Copenhagen	Phase 4
Unknown	Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicine Departments With Nutritional NCT03802942	Eyal Leibovitz	Phase 3
Completed	The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Dia NCT03734718	Steno Diabetes Center Copenhagen	N/A
Completed	Effect of Fasting on Insulin-induced Hypoglycemia Counterregulation in Healthy Humans NCT04392843	University of Cincinnati	N/A
Completed	Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas NCT03859401	Marc Breton	N/A
Completed	A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients Wit NCT03895697	Zealand Pharma	Phase 3
Completed	Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety After Gastric Surgery NCT03353415	Joslin Diabetes Center	N/A
Active Not Recruiting	Hypoglycemia and the Gut Microbiome NCT03385707	Joslin Diabetes Center	—
Completed	The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism NCT03868657	Signe Torekov	N/A
Terminated	Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF) NCT03608163	Albert Einstein College of Medicine	Phase 4
Terminated	Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglyca NCT03748433	Imperial College London	N/A
Completed	Hypoglycemia and Cardiac Arrhythmias in Type 1 Diabetes NCT03956173	Steno Diabetes Center Copenhagen	—
Completed	Effect of Dapagliflozin on IAH in T1DM NCT03556033	Radboud University Medical Center	Phase 2
Completed	Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compare NCT03735225	Zealand Pharma	Phase 1
Completed	Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects NCT03688711	Zealand Pharma	Phase 3
Completed	Correlation Between Exercise and Insulin Dose in a Camp for Pediatric Type 1 Patients NCT03725657	University of Campania Luigi Vanvitelli	—
Completed	Prediction and Prevention of Nocturnal Hypoglycemia in Persons With Type 1 Diabetes Using Machine Learning Tec NCT03711656	Hospital Clinic of Barcelona	N/A
Completed	Prevention Through Intervention: Telehealth Solution to Deter 911 Calls Due to Hypoglycemia NCT03665870	University of Alabama at Birmingham	N/A
Completed	Role of CGMS Usage in Predicting Risk for Hypoglycemia NCT03481530	University of Minnesota	—
Unknown	Antenatal Betamethasone and the Risk of Neonatal Hypoglycemia NCT03702959	Rambam Health Care Campus	—
Completed	Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children NCT03667053	Zealand Pharma	Phase 3
Completed	Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients NCT03406897	Rodolfo Alejandro	Phase 1 / Phase 2
Active Not Recruiting	Continuous Glucose Monitoring Devices in Hospitalized Veterans With Diabetes NCT03508934	VA Office of Research and Development	N/A
Completed	Telemedicine Monitoring of Nocturnal Incidents NCT04328896	University of Southern California	N/A
Unknown	Diabetes and Cognitive Functions in Middle Age NCT05919927	Tampere University Hospital	—
Completed	Lipohypertrophy Monitoring Study NCT04659330	University Hospital, Antwerp	N/A
Completed	Biomarkers in Exhaled Breath of Glucose Fluctuation in Type 1 Diabetes NCT03435198	East Tennessee State University	—
Unknown	A Combined Biofeedback-virtual Reality System for Reduction of Fear of Hypoglycemia NCT02380339	Hadassah Medical Organization	N/A
Completed	Impact of Hypoglycaemia in Patients With Diabetes Mellitus Type 2 on Platelet Activation NCT03460899	Medical University of Graz	N/A
Completed	A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes NCT03378635	Zealand Pharma	Phase 3
Terminated	Frequency of Hypoglycemia in Patients With Type 2 Diabetes Under Insulin Therapy Older Than 75 Years in Real L NCT03020264	Nantes University Hospital	N/A
Completed	A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus NCT03339453	Eli Lilly and Company	Phase 1
Completed	Hypoglycemia and Autonomic Nervous System Function- B2 NCT03422471	Brigham and Women's Hospital	N/A
Completed	Hybrid Closed Loop Insulin Delivery System in Hypoglycemia NCT03215914	University of Pennsylvania	N/A
Completed	A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus NCT03216226	Zealand Pharma	Phase 3
Completed	FreeStyle Libre FGM During Summer Camp for Children With Type 1 Diabetes NCT03182842	University of Ljubljana, Faculty of Medicine	N/A
Completed	Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 Diabetes NCT03014011	Bispebjerg Hospital	N/A
Completed	Exercise Physiology Study NCT03090451	Oregon Health and Science University	N/A
Completed	Insulin Management for Exercise in Patients With Type 1 Diabetes NCT03130101	York University	N/A
Completed	Technological Advances in Glucose Management in Older Adults NCT03078491	Joslin Diabetes Center	N/A
Terminated	Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk NCT03246243	Boston Children's Hospital	—
Completed	Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics NCT02656069	Xeris Pharmaceuticals	Phase 3
Completed	Hypoglycaemia Awareness Restoration Programme NCT02940873	King's College London	N/A
Completed	Comparison Between Hypoglycemic Counter Regulatory Responses in Type 1 Diabetics vs Control Subjects NCT03034226	University of Aarhus	N/A
Completed	Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes NCT02735031	Radboud University Medical Center	Phase 2 / Phase 3
Active Not Recruiting	Adrenergic System in Islet Transplantation NCT03079921	University of Pennsylvania	EARLY_Phase 1
Completed	Hypoglycemia Prediction Model NCT03006510	University of California, San Francisco	N/A
Completed	Identifying the Brain Substrates of Hypoglycemia Unawareness in Type 1 Diabetes NCT02866435	University of Minnesota	EARLY_Phase 1
Completed	Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population NCT03482154	University of Colorado, Denver	—
Unknown	Dose Response Oxidation of a Sweet-corn Derived Sugar (PhytoSpherix) During Exercise in Endurance Trained Athl NCT02909881	University of Western Ontario, Canada	N/A
Completed	Post Bariatric Closed Loop Glucagon Trial NCT02966275	Massachusetts General Hospital	N/A
Completed	The Late Effects of Ethanol Intake on the Glucose Response to Subcutaneous Glucagon in Type 1 Diabetes NCT02881060	Hvidovre University Hospital	Phase 4
Completed	Dextrose Gel Does Not Prevent Neonatal Hypoglycemia NCT02523222	Baylor College of Medicine	Phase 2 / Phase 3
Terminated	T1 Diabetes Hypoglycemia Prevention Pilot NCT02682940	InSpark Technologies, Inc.	N/A
Completed	Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension NCT02714972	Jaeb Center for Health Research	Phase 2
Terminated	A Pilot Study of Nocturnal Hypoglycemia Prevention in Type 1 Diabetes Using the Vigilant Diabetes Management C NCT02906891	InSpark Technologies, Inc.	N/A
Unknown	GLP1R-imaging in Hypoglycemia NCT03182192	Radboud University Medical Center	Phase 1
Completed	An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery NCT02772718	XOMA (US) LLC	Phase 2
Completed	Continuous Glucose Monitoring in New Mothers With Type 1 Diabetes NCT02898428	Steno Diabetes Center Copenhagen	—
Completed	Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Pat NCT02733588	Xeris Pharmaceuticals	Phase 2
Completed	Effect of Hypoglycemia on Sleep NCT02687893	Oregon Health and Science University	N/A
Completed	Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance Spectroscopy NCT02690168	Pennington Biomedical Research Center	—
Completed	Primary Care Clinicians' Responses to a Hypoglycemia Risk Calculator for Diabetes Mellitus in Ambulatory Care NCT04177147	Indiana University	N/A
Completed	Single Doses of ZP4207 Adm. sc to Hypoglycemic TD1 pt. to Describe the PK and PD of ZP4207 as Comp. to Markete NCT02660008	Zealand Pharma	Phase 2
Completed	Simplification of Complex Insulin Regimens With Preserving Good Glycemic Control in Type 2 Diabetes NCT04020445	Bekes County Central Hospital	—
Completed	Outcomes Study of MTM in a Medicare ACO NCT02875925	HealthEast Care System	N/A
Completed	Treatment of Hypoglycemia Following Gastric Bypass Surgery NCT02527993	Zealand University Hospital	Phase 4
Completed	Glucagon Efficiency After High and Low Carbohydrate Diet NCT02578498	Hvidovre University Hospital	Phase 4
Withdrawn	How to be Safe With Alcoholic Drinks in Diabetes NCT02518022	Kinderkrankenhaus auf der Bult	N/A
Recruiting	Differing Levels of Hypoglycemia NCT02445781	University of Maryland, Baltimore	EARLY_Phase 1
Completed	Multiple Ascending Doses of ZP4207 Administered to HV to Evaluate the Safety, Tolerability, PKs and PDs of ZP4 NCT02390141	Zealand Pharma	Phase 1
Completed	G-Pen™ for Hypoglycemia Rescue in T1D Patients NCT02423980	Xeris Pharmaceuticals	Phase 2
Completed	Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents NCT02402933	Eli Lilly and Company	Phase 3
Completed	Hypoglycemia (Low Blood Sugar) and the Heart NCT01980914	University of British Columbia	N/A
Terminated	Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia NCT02300285	Boston Children's Hospital	N/A
Completed	Suspending Basal Insulin Levels for Exercise in Adults With Type 1 Diabetes NCT03034798	York University	—
Completed	Safety and Efficacy of ZP-Glucagon to Injectable Glucagon for Hypoglycemia NCT02459938	Zosano Pharma Corporation	Phase 1
Completed	Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin Therapy NCT02424500	Hygieia Research LLC	N/A
Completed	Single Ascending Doses of ZP4207 Administered in HV and in T1D to Evaluate Safety, Tolerability PKs and PDs of NCT02367053	Zealand Pharma	Phase 1
Completed	Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons NCT02403648	Biodel	Phase 1
Completed	Allogeneic Islet Cells Transplanted Onto the Omentum NCT02213003	Rodolfo Alejandro	Phase 1 / Phase 2
Completed	Hypoglycemia in Hospitalized Patients NCT02228642	University of Pittsburgh	—
Completed	Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight NCT02176096	University of Manitoba	N/A
Completed	Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia NCT02171130	Eli Lilly and Company	Phase 3
Completed	Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes NCT02081014	Xeris Pharmaceuticals	Phase 2
Completed	PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients NCT02081001	Xeris Pharmaceuticals	Phase 2
Completed	Impact of Physical Activity on Blood Glucose Stability and Energy Stores in Individuals With Type 1 Diabetes NCT02068638	Insel Gruppe AG, University Hospital Bern	N/A
Terminated	CREON for the Treatment of Post-RYGB Hypoglycemia NCT02733848	East Carolina University	Phase 1
Terminated	Role of GLP-1 in Hyperinsulinemic Hypoglycemia Post-bariatric Surgery NCT02550145	Tracey McLaughlin	Phase 1
Completed	Multicentre LOGIC-Insulin Algorithm-guided Versus Nurse-directed Blood Glucose Control During Critical Illness NCT02056353	KU Leuven	N/A
Completed	Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimep NCT02007278	Novartis Pharmaceuticals	Phase 4
Completed	Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis NCT02083133	Cook County Health	—
Completed	Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to NCT01972152	Xeris Pharmaceuticals	Phase 2
Completed	Intracellular Counter-regulatory Mechanisms Following Low Blood Glucose NCT01919788	University of Aarhus	N/A
Completed	Hypoglycemia and Autonomic Nervous System Function-B NCT03429946	Brigham and Women's Hospital	Phase 4
Completed	Hypoglycemia in Prader-Willi Syndrome NCT01897363	University of Florida	—
Completed	Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia NCT01865760	University of Aarhus	N/A
Completed	Brain Ketone Metabolism in Type 1 Diabetes NCT02471040	Yale University	Phase 1
Completed	Hippocampal Metabolism and Function in Patients With Type 1 Diabetes NCT01852968	University of Minnesota	—
Completed	Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedfor NCT02086227	Fresenius Kabi USA, LLC	Phase 1
Completed	The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass NCT02336438	Bassett Healthcare	Phase 4
Terminated	Monitoring Glucose Levels in Patients With Myocardial Infarction NCT03107806	Lars Ryden	N/A
Completed	Hypoglycemia Requiring Emergency Services Intervention: Patient Characteristics, Outcome and Cardiovascular Ri NCT04422145	University of Leeds	N/A
Completed	Hypoglycaemia in People With Type 2 Diabetes in Primary Care NCT02666521	University of Leicester	—
Completed	GIP and GLP-1 in Type 1 Diabetes NCT01739283	Mikkel Christensen	N/A
Completed	Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypo NCT01556594	Eli Lilly and Company	Phase 2
Unknown	Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients NCT01525784	Assaf-Harofeh Medical Center	—
Completed	Identifying Driving Risk Factors in Type 1 Diabetes and Their Reduction Via Internet Program (DiabetesDriving. NCT01563887	University of Virginia	N/A
Completed	Acute Maternal and Fetal Effects of Exercise in Pregnancy NCT01383889	Instituto Materno Infantil Prof. Fernando Figueira	N/A
Completed	Effect of Different Plasma Insulin Levels on the Accuracy of Continuous Subcutaneous Glucose Monitoring NCT01714895	Fundación para la Investigación del Hospital Clínico de Valencia	N/A
Completed	Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia NCT01462227	Yale University	N/A
Withdrawn	Lactate to Treat Hypoglycemia NCT01387477	Institut d'Anesthesiologie des Alpes Maritimes	Phase 4
Completed	Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand NCT02056249	Yale University	—
Completed	Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery NCT01272583	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	N/A
Completed	Maternal Lifestyle and Neonatal Hypoglycemia NCT01409382	Hospital dos Servidores do Estado do Rio de Janeiro	N/A
Unknown	Pilot Study of Intensive Care Unit Continuous Glucose Monitoring NCT01301053	University of Virginia	N/A
Completed	Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery NCT01283126	Joslin Diabetes Center	N/A
Completed	Hypoglycemia and the Mineralocorticoid Receptor NCT01394627	Brigham and Women's Hospital	N/A
Terminated	Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - a Pilot Study NCT01238016	UNEEG Medical A/S	N/A
Completed	Hypoglycemia: Physician and Patient Perspectives NCT01176656	AstraZeneca	—
Completed	Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes NCT01147276	Lund University	Phase 4
Completed	Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin Syste NCT01116180	Louise Faerch	N/A
Completed	Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery NCT01841359	Joslin Diabetes Center	Phase 4
Completed	Identification of Inpatients at Risk for Poor Glycemic Control NCT01043042	Vanderbilt University Medical Center	—
Recruiting	Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery NCT00992901	The University of Texas Health Science Center at San Antonio	EARLY_Phase 1
Unknown	Diazoxide In the Management Of Hypoglycemic Neonates NCT00994149	University of Saskatchewan	Phase 2 / Phase 3
Completed	Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge NCT00998374	Medtronic - MITG	—
Terminated	Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabete NCT00869414	Johns Hopkins University	N/A
Completed	Intravenous Exenatide (Byetta) During Surgery NCT00882050	Thomas Jefferson University	Phase 1 / Phase 2
Completed	Associated Factors in Perioperative Hypoglycemia in Patients With Diabetes NCT00826007	Corewell Health East	—
Completed	Idiopathic Reactive Hypoglycaemia and Treatment With Fructo-Oligosaccharide NCT00802971	Asker & Baerum Hospital	N/A
Terminated	The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients NCT00798590	Johns Hopkins University	Phase 2
Completed	GLP 1 for Intraoperative Glycemic Control NCT00882492	University of Pennsylvania	Phase 1
Completed	Investigating the Accuracy of the Home Glucose Monitors in Hypoglycemia NCT01013402	Gulhane School of Medicine	Phase 4
Completed	Real-time Continuous Glucose Monitoring in Very Low Birth Weight Neonates NCT01942239	University Hospital, Tours	N/A
Completed	International Navigator Hypoglycaemia Study NCT00843609	University Medical Centre Ljubljana	N/A
Terminated	Tight Glycaemic Control During Cardiac Surgery NCT01225159	Prince of Songkla University	N/A
Terminated	Sitagliptin Versus Sulphonylurea in Type 2 Diabetes During Ramadan NCT00766441	University of Manchester	Phase 4
Completed	Treatment With Erythropoietin and Cognition During Hypoglycaemia NCT00615368	Hillerod Hospital, Denmark	N/A
Unknown	Mechanisms of Hypoglycemia Associated Autonomic Failure NCT00678145	Albert Einstein College of Medicine	Phase 2
Completed	Computer Decision Support to Achieve Glycemic Control in the ICU NCT00589589	United States Army Institute of Surgical Research	Phase 1
Unknown	Inpatient Self Monitoring and Administration Study (ISMAS) NCT00506272	Atlanta VA Medical Center	N/A
Completed	Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers NCT00434772	Shaare Zedek Medical Center	Phase 2
Unknown	Observational Study of Infants Born at 34 to 37 Weeks of Gestation Until the Age of 1 Year NCT00550069	Sheba Medical Center	—
Terminated	Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes NCT00672204	University of Minnesota	Phase 1 / Phase 2
Completed	Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients NCT00937079	University Hospital, Basel, Switzerland	—
Completed	Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo NCT00745186	Hospira, now a wholly owned subsidiary of Pfizer	Phase 1
Completed	Influence of Dietary Fiber-rich Meals on Gene Expression and Postprandial Glucose and Lipid Response NCT01005342	Lund University	N/A
Completed	Effect of Continuous Glucose Monitoring on Course of Glucose in Type 1 Diabetes NCT00467688	Forschungsinstitut der Diabetes Akademie Mergentheim	N/A
Completed	EEG-Changes During Insulininduced Hypoglycemia in Type 1 Diabetes NCT00810420	UNEEG Medical A/S	—
Withdrawn	Effects of Pulsatile Intravenous Insulin Delivery on Hypoglycemic Unawareness NCT01029639	Florida Atlantic University	Phase 2 / Phase 3
Completed	Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes NCT00641407	University of Campania Luigi Vanvitelli	Phase 4
Completed	Using Glucose Sensors to Prevent Hypoglycemia NCT00554281	University of Alberta	Phase 3
Completed	Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus NCT00453375	Bayhill Therapeutics	Phase 1
Completed	Adrenaline Injections to Children Born at Elective CS NCT00322660	Hvidovre University Hospital	N/A
Terminated	Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir NCT00490893	University Hospital Tuebingen	Phase 4
Withdrawn	Blood Sugars in Children With Idiopathic Seizures. NCT00279851	Children's Mercy Hospital Kansas City	—
Completed	The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study NCT00264641	Hypoglycaemia Research Group	N/A
Completed	MGA031, Sirolimus and Tacrolimus in Islet Transplantation NCT00265473	University of Minnesota	Phase 1 / Phase 2
Completed	Study of How Low Blood Sugar Affects the Way Blood Vessels Work NCT00373854	Ohio State University	—
Completed	Impact of Hypoglycemia Unawareness on Brain Metabolism Cognition in T1DM NCT00575783	Yale University	—
Completed	Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia NCT00804297	Albert Einstein Healthcare Network	Phase 3
Completed	NAET® Testing Devices in Detection of Hypersensitivity to Cane Sugar NCT00292578	Nambudripad's Allergy Research Foundation	Phase 1 / Phase 2
Completed	Carnitine Levels and Carnitine Supplementation in Type I Diabetes NCT00351234	Children's Mercy Hospital Kansas City	—
Completed	Hypoglycemia and Autonomic Nervous System Function NCT01816893	Brigham and Women's Hospital	N/A
Completed	Skittles(TM) Effective for Treating Hypoglycemia in Children With Type 1 Diabetes NCT00706693	University of Calgary	N/A
Completed	Islet Allotransplantation With Steroid Free Immunosuppression NCT00446264	University Hospital, Lille	Phase 2
Completed	Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation NCT00286624	University of Minnesota	Phase 1 / Phase 2
Completed	Late Night Snack and Insulin Glargine NCT02871180	Diabeteszentrum Bad Lauterberg im Harz	N/A
Completed	Investigation Into the Effects Upon Brain Response to Change in Circulating Glucose Levels in Diabetes Mellitu NCT00580710	Yale University	—
Completed	Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes NCT00285233	University of Minnesota	Phase 1 / Phase 2
Completed	hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients NCT00285194	University of Minnesota	Phase 1 / Phase 2
Recruiting	Diagnosing and Treating Low Blood Sugar Levels NCT00001276	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	—
Completed	Disorders of Systemic Glucose Balance NCT00006508	National Center for Research Resources (NCRR)	N/A
No Longer Available	Islet Transplant for Type 1 or Surgical Diabetes NCT01606475	University of Minnesota	—